47.82
price down icon1.77%   -0.86
after-market Dopo l'orario di chiusura: 48.22 0.40 +0.84%
loading
Precedente Chiudi:
$48.68
Aprire:
$48.33
Volume 24 ore:
4.95M
Relative Volume:
1.67
Capitalizzazione di mercato:
$116.15B
Reddito:
$43.23B
Utile/perdita netta:
$6.79B
Rapporto P/E:
11.94
EPS:
4.0051
Flusso di cassa netto:
$9.17B
1 W Prestazione:
-1.28%
1M Prestazione:
-8.29%
6M Prestazione:
-3.72%
1 anno Prestazione:
+2.18%
Intervallo 1D:
Value
$46.97
$48.61
Intervallo di 1 settimana:
Value
$46.97
$49.24
Portata 52W:
Value
$44.62
$60.12

Sanofi Adr Stock (SNY) Company Profile

Name
Nome
Sanofi Adr
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
82,878
Name
Cinguettio
@sanofi
Name
Prossima data di guadagno
2025-10-24
Name
Ultimi documenti SEC
Name
SNY's Discussions on Twitter

Confronta SNY con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - General icon
SNY
Sanofi Adr
47.82 118.24B 43.23B 6.79B 9.17B 4.0051
Drug Manufacturers - General icon
LLY
Lilly Eli Co
1,062.19 919.64B 59.42B 18.41B 6.44B 20.22
Drug Manufacturers - General icon
JNJ
Johnson Johnson
214.17 509.76B 92.15B 25.12B 20.46B 10.36
Drug Manufacturers - General icon
ABBV
Abbvie Inc
227.45 394.69B 59.64B 2.36B 19.68B 1.3253
Drug Manufacturers - General icon
NVS
Novartis Ag Adr
135.19 254.37B 54.45B 14.42B 17.15B 7.333
Drug Manufacturers - General icon
MRK
Merck Co Inc
100.26 248.95B 63.90B 19.05B 13.05B 7.5596

Sanofi Adr Stock (SNY) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-12-09 Downgrade Guggenheim Buy → Neutral
2025-12-08 Downgrade JP Morgan Overweight → Neutral
2025-09-08 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2025-09-02 Aggiornamento Deutsche Bank Hold → Buy
2025-08-08 Aggiornamento JP Morgan Neutral → Overweight
2025-04-15 Iniziato Exane BNP Paribas Outperform
2025-03-21 Iniziato Goldman Neutral
2025-01-30 Aggiornamento Deutsche Bank Sell → Hold
2024-07-26 Reiterato Argus Buy
2024-01-23 Iniziato Morgan Stanley Equal-Weight
2024-01-16 Ripresa UBS Buy
2023-12-05 Downgrade JP Morgan Overweight → Neutral
2023-10-30 Downgrade Stifel Buy → Hold
2023-09-06 Aggiornamento Berenberg Hold → Buy
2023-07-14 Iniziato HSBC Securities Buy
2023-04-28 Downgrade Deutsche Bank Hold → Sell
2023-03-27 Aggiornamento Barclays Equal Weight → Overweight
2022-12-13 Ripresa Morgan Stanley Overweight
2022-08-12 Aggiornamento Deutsche Bank Sell → Hold
2022-08-09 Downgrade UBS Buy → Neutral
2022-05-23 Iniziato SVB Leerink Outperform
2021-09-27 Aggiornamento SVB Leerink Mkt Perform → Outperform
2021-01-15 Iniziato Deutsche Bank Sell
2020-09-29 Iniziato Berenberg Hold
2020-03-17 Aggiornamento Barclays Underweight → Equal Weight
2020-03-11 Aggiornamento Goldman Neutral → Buy
2020-02-11 Iniziato SVB Leerink Mkt Perform
2020-01-06 Aggiornamento JP Morgan Neutral → Overweight
2019-09-23 Aggiornamento Guggenheim Neutral → Buy
2019-09-20 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2019-09-03 Iniziato Bernstein Outperform
2019-08-14 Aggiornamento UBS Neutral → Buy
2018-12-11 Aggiornamento Jefferies Hold → Buy
2018-11-01 Aggiornamento Barclays Underweight → Equal Weight
2018-10-09 Iniziato Guggenheim Neutral
2018-09-10 Aggiornamento BofA/Merrill Neutral → Buy
2018-08-10 Aggiornamento Citigroup Neutral → Buy
2018-03-23 Aggiornamento Liberum Hold → Buy
2018-01-23 Downgrade Barclays Equal Weight → Underweight
2017-12-06 Downgrade BofA/Merrill Buy → Neutral
2017-12-01 Downgrade Morgan Stanley Overweight → Underweight
2017-11-15 Aggiornamento Barclays Underweight → Equal Weight
2017-08-30 Aggiornamento HSBC Securities Reduce → Hold
Mostra tutto

Sanofi Adr Borsa (SNY) Ultime notizie

pulisher
06:41 AM

Sanofi (SNY) sees slight pessimism from analysts - MSN

06:41 AM
pulisher
02:51 AM

Sanofi: Today's Tolebrutinib Setback Shouldn't Worry ShareholdersThis Is Why (SNY) - Seeking Alpha

02:51 AM
pulisher
01:10 AM

Sanofi Expands Dren Bio Partnership With Potential $1.7 Billion Autoimmune Disease Collaboration - Benzinga

01:10 AM
pulisher
06:10 AM

Sanofi Stock (SAN.PA, SNY) Slides After Tolebrutinib Double Setback: FDA Delay, Trial Miss, and Fresh Analyst Forecasts (Dec. 15, 2025) - ts2.tech

06:10 AM
pulisher
Dec 12, 2025

Sanofi (SNY) Sees Slight Pessimism From Analysts - Finviz

Dec 12, 2025
pulisher
Dec 10, 2025

JPMorgan Downgrades Sanofi (SNY) to EUR 95 from EUR 105 - Finviz

Dec 10, 2025
pulisher
Dec 10, 2025

TEVA Files NDA With FDA for Olanzapine LAI for Schizophrenia - Finviz

Dec 10, 2025
pulisher
Dec 10, 2025

Why Wall Street Analysts Are Closely Watching Sanofi (SNY) - Finviz

Dec 10, 2025
pulisher
Dec 09, 2025

Teva Stock Trading Above 200- & 50-Day SMA for 2 Months: How to Play - Finviz

Dec 09, 2025
pulisher
Dec 09, 2025

KYMR Stock Surges on Upbeat Data From KT-621 Atopic Dermatitis Study - Finviz

Dec 09, 2025
pulisher
Dec 09, 2025

Drugmakers Briefed As Vaccine Skeptics Like RFK Jr. Probe RSV Therapy Risks - Sahm

Dec 09, 2025
pulisher
Dec 01, 2025

REGN Gains 21.5% in a Month: Time to Buy, Sell or Hold the Stock? - Finviz

Dec 01, 2025
pulisher
Nov 28, 2025

Deutsche Bank Maintains a Buy Rating on Sanofi (SNY) - Finviz

Nov 28, 2025
pulisher
Nov 26, 2025

Kymera Trades Near 52-Week High: Time to Buy, Sell or Hold the Stock? - Finviz

Nov 26, 2025
pulisher
Nov 25, 2025

SNY & REGN's Dupixent Gets EU Nod for Chronic Spontaneous Urticaria - Finviz

Nov 25, 2025
pulisher
Nov 25, 2025

Sanofi Faces Surprise HQ Search As French Authorities Expand Tax Probe - Sahm

Nov 25, 2025
pulisher
Nov 23, 2025

Bloom Energy-Aktie: Vorsicht geboten! - Finanztrends

Nov 23, 2025
pulisher
Nov 22, 2025

Abbott-Aktie: 21 Milliarden Dollar für neues Wachstum! - Finanztrends

Nov 22, 2025
pulisher
Nov 21, 2025

Texas AG Sues Sanofi And Bristol-Myers Over Alleged Failures To Warn About Risks Associated With Blood Thinner Drug - Sahm

Nov 21, 2025
pulisher
Nov 21, 2025

Wasserstoff-Aktien: Bloom Energy kollabiert erneut, Nel ASA gibt nicht auf und Primary Hydrogen meldet Fortschritte! - Finanztrends

Nov 21, 2025
pulisher
Nov 21, 2025

A Technical View of the Leifras Co Ltd ADR (LFS) - fostersleader.com

Nov 21, 2025
pulisher
Nov 17, 2025

Eli Lilly Upgraded, Chewy Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace

Nov 17, 2025
pulisher
Nov 10, 2025

Why Roche Holding Stock Popped Today - Finviz

Nov 10, 2025
pulisher
Nov 07, 2025

Novavax Q3 Earnings & Revenues Beat Estimates, '25 Sales View Raised - Finviz

Nov 07, 2025
pulisher
Oct 28, 2025

Regeneron's Q3 Earnings Outperform Expectations With Dupixent Strength Balancing Eylea Weakness - Sahm

Oct 28, 2025
pulisher
Oct 27, 2025

UPDATE - GlobeNewswire Inc.

Oct 27, 2025
pulisher
Oct 24, 2025

Sanofi ADR earnings beat by $0.72, revenue fell short of estimates - Investing.com Nigeria

Oct 24, 2025
pulisher
Oct 24, 2025

Dupixent Pushes Sanofi's Quarterly Sales Past $14.5 Billion Mark - Sahm

Oct 24, 2025
pulisher
Oct 22, 2025

Sanofi Drug Shows Superior Efficacy In Genetic Disease Compared To Current Standard Therapy - Sahm

Oct 22, 2025

Sanofi Adr Azioni (SNY) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$119.78
price down icon 0.51%
drug_manufacturers_general PFE
$26.43
price up icon 2.24%
$325.31
price up icon 2.38%
drug_manufacturers_general NVO
$50.37
price up icon 0.38%
drug_manufacturers_general MRK
$100.26
price down icon 0.04%
Capitalizzazione:     |  Volume (24 ore):